Back to ESPR

Esperion Therapeutics, Inc. 10-Q

Accession 0001628280-26-032870

Filing information

CIK
0001434868
Report date
2026-03-31
Filing date
2026-05-08
Form
10-Q
Primary document
espr-20260331.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.